Target intelligence / Profile preview

Polymodal nociceptor (None established)

Target
None established
Molecular classification
Other (sensory neuron ending/class), Not an individual protein/receptor/enzyme/transporter, Often associated with unmyelinated C fibers and sometimes Aδ fibers, May express various ion channels and G protein-coupled receptors such as TRPV1, Mrgprd, etc.
01

Overview

A polymodal nociceptor is a type of sensory nerve ending found primarily in skin and subcutaneous tissue that responds to multiple types (“modalities”) of potentially damaging stimuli—including mechanical pressure/stretching, heat/cold extremes, and chemical irritants. Most commonly associated with unmyelinated C fibers—and less frequently Aδ fibers—these units play an essential role in detecting noxious events that cause tissue damage (“pain”). They exhibit plasticity/sensitization after injury or inflammation—a process underlying primary hyperalgesia seen clinically after burns or trauma. While they express various ion channels and GPCRs involved in stimulus detection/transduction (e.g., TRPV1 for heat/capsaicin/protons; Mrgprd for nonpeptidergic signaling), there is no single “polymodal receptor” molecule suitable as a canonical drug target name—the term refers instead to the functional property shared by this group of afferent neurons rather than any one gene/protein product[1][2][3][4].

Other names
C-fiber polymodal nociceptorPolymodal nociceptorPMR (rarely)Cutaneous polymodal receptor
02

Mechanism of action

Not applicable for the “receptor” itself; see above regarding indirect modulation through other targets.

03

Biological functions

Nociception (pain detection)Signal transduction of mechanical, thermal (heat/cold), and chemical noxious stimuliSensitization after injury/inflammation ("plasticity")
04

Disease associations

Pain syndromes/chronic painInflammatory pain/hyperalgesiaNeuropathic pain/post-injury sensitization
05

Safety considerations

Non-specific inhibition can lead to loss of protective pain sensation.Targeting broad classes risks side effects due to widespread distribution/function.
06

Interacting drugs

TRPV1 antagonists/agonists (indirect modulation)

3 more in the full profile.

07

Biomarkers

None specific to “polymodal receptors.”Expression of certain neuropeptides like substance P and CGRP in subsets of these neuronsExpression of Mrgprd or TRPV1 channels in subpopulations

Beyond the preview

Go deeper on Polymodal nociceptor (None established).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polymodal nociceptor (None established).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call